Bioage Labs Inc (BIOA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -48,350 | -22,253 | -80,605 | -54,662 | -34,491 |
| Depreciation Amortization | 133 | 63 | 213 | 144 | 95 |
| Accounts receivable | 144 | 60 | -769 | -515 | -603 |
| Accounts payable and accrued liabilities | 2,906 | 326 | 788 | 3,095 | -550 |
| Other Working Capital | -3,175 | -5,994 | -11,828 | -8,092 | -9,319 |
| Other Operating Activity | 5,036 | 3,752 | 10,574 | 6,654 | 7,536 |
| Operating Cash Flow | $-43,306 | $-24,046 | $-81,627 | $-53,376 | $-37,332 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -210,913 | -46,727 | 60,250 | -80,181 | -93,044 |
| PPE Investments | -354 | -26 | -155,466 | -607 | -585 |
| Investing Cash Flow | $-211,267 | $-46,753 | $-95,216 | $-80,788 | $-93,629 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | -1,500 | -6,000 | -4,500 | N/A |
| Debt Repayment | -2,000 | N/A | N/A | N/A | -3,000 |
| Common Stock Issued | 143,347 | 126,022 | 714 | N/A | N/A |
| Other Financing Activity | -1,666 | -807 | 16,755 | -44 | 0 |
| Financing Cash Flow | $139,681 | $123,715 | $11,469 | $-4,544 | $-3,000 |
| Exchange Rate Effect | -32 | -27 | -87 | -68 | -58 |
| Beginning Cash Position | 188,888 | 188,888 | 354,349 | 354,349 | 354,349 |
| End Cash Position | 73,964 | 241,777 | 188,888 | 215,573 | 220,330 |
| Net Cash Flow | $-114,924 | $52,889 | $-165,461 | $-138,776 | $-134,019 |
| Free Cash Flow | |||||
| Operating Cash Flow | -43,306 | -24,046 | -81,627 | -53,376 | -37,332 |
| Capital Expenditure | -354 | -26 | -155,466 | -607 | -585 |
| Free Cash Flow | -43,660 | -24,072 | -237,093 | -53,983 | -37,917 |